Patents by Inventor Sheila M.J. AUBIN

Sheila M.J. AUBIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Detecting or Quantifying Hepatitis C Virus
    Publication number: 20220389525
    Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis C virus (HCV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the 5? untranslated region of HCV and are configured to provide substantially equivalent quantification of different genotypes and variants of HCV.
    Type: Application
    Filed: June 27, 2022
    Publication date: December 8, 2022
    Applicant: Gen-Probe Incorporated
    Inventors: Siobhan Miick, Paul M. Darby, Jo Ann Jackson, Sheila M.J. Aubin
  • Compositions and methods for detecting or quantifying hepatitis C virus
    Patent number: 11447835
    Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis C virus (HCV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the 5? untranslated region of HCV and are configured to provide substantially equivalent quantification of different genotypes and variants of HCV.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: September 20, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Siobhan Miick, Paul M. Darby, Jo Ann Jackson, Sheila M. J. Aubin
  • COMPOSITIONS AND METHODS FOR DETECTING OR QUANTIFYING HEPATITIS C VIRUS
    Publication number: 20180291474
    Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis C virus (HCV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the 5? untranslated region of HCV and are configured to provide substantially equivalent quantification of different genotypes and variants of HCV.
    Type: Application
    Filed: October 18, 2017
    Publication date: October 11, 2018
    Inventors: Siobhan MIICK, Paul M. DARBY, Jo Ann JACKSON, Sheila M.J. AUBIN